Rational Pharmacotherapy in Cardiology

Advanced search


Full Text:


A review of international recommendations, including methods to assist in smoking cessation is presented. Particular attention is paid to the recommendations for treatment and prevention of cardiovascular disease. There are a lot of approaches to drop smoking including innovative pharmacotherapy. Implementation of these approaches is rational at all steps of health care for cardiovascular patients.

About the Author

M. S. Berezhnova
St. Petersburg State Chemical and Pharmaceutical Academy
Russian Federation


1. Cardiovascular disease. WHO Fact Sheet. January 2011; Fact sheet N°317. Available on: Date of access 24.08.11

2. Strategy for the prevention and control of noncommunicable diseases and injuries in the Russian Federation. Moscow: Ministry of Health and the Russian Federation; 2008. Available on: Date of access 25.08.11. Russian (Стратегия профилактики и контроля неинфекционных заболеваний и травматизма в Российской Федерации. М.: МЗ и СР РФ; 2008. Доступно на: Дата доступа 25.08.11).

3. Allender S., Scarborough P., Peto V., Rayner M.; British Heart Foundation Health Promotion Research Group, Department of Public Health, University of Oxford; Leal J., Luengo-Fernandez R., Gray A.; Health Economic Research Group, Department of Public Health, University of Oxford. European cardiovascular disease statistics 2008. Available on: Date of access 25.08.11

4. Press Release EURO/05/06, Copenhagen, 11 September 2006. Available on: centre/PR/2006/20060908_1. Date of access 24.08.11

5. The concept of the health system of the Russian Federation until 2020. Available on: Date of access 25.08.11. Russian (Концепция развития системы здравоохранения Российской Федерации до 2020 года. Доступно на: Дата доступа 25.08.11).

6. Chazov E.I., Boytsov S.A. The development of modern medical technologies and organizational management of acute coronary syndrome as an important condition for reducing cardiovascular mortality in the Russian Federation. Bolezni serdtsa i sosudov 2008; 4:4-11. Russian (Чазов Е.И., Бойцов С.А. Развитие современных организационных и лечебных технологий лечения острого коронарного синдрома как важное условие снижения сердечно-сосудистой смертности в Российской Федерации. Болезни сердца и сосудов 2008; 4:4-11).

7. Belenkov Yu.N., Oganov R.G., eds. Cardiology: national guidelines. Moscow: GEOTAR-Media; 2007. Russian (Беленков Ю.Н., Оганов Р.Г., редакторы. Кардиология: национальное руководство. М.: ГЭОТАР-Медиа; 2007).

8. Shal'nova S.A., Deev A.D. Characteristics of patients at high riska.Rezultaty of epidemiological research and educational programs OSCAR. Kardiovaskulyarnaya terapiya i profilaktika 2006;6:58—63. Russian (Шальнова С.А., Деев А.Д. Характеристика пациентов высокого риска. Результаты эпидемиологической части научно-образовательной программы ОСКАР. Кардиоваскулярная терапия и профилактика 2006;6:58—63).

9. National guidelines for rational pharmacotherapy of patients with cardiovascular diseases. M: VNOK; 2009. Available on: Date of access 25.08.11. Russian (Рекомендации по рациональной фармакотерапии больных сердечно-сосудистыми заболеваниями. M: ВНОК; 2009; с. 17 Доступен на: Дата доступа 25.08.11)

10. Global survey of adults about tobacco use. Russian Federation, 2009. Country Report. Available on: Date of access 24.08.11. Russian. Глобальный опрос взрослого населения о потреблении табака. Российская Федерация 2009. Страновой отчет. Доступен на: ru_tfi_gatsrussian_countryreport.pdf. Дата доступа 24.08.11

11. Ford E.S., Ajani U.A., Croft J.B. et al. Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med 2007; 356: 2388–98.

12. Fiore M.C., Jaen C.R., Baker T.B. et al. Treating tobacco use and dependence: 2008 update: clinical practice guideline. US Department of Health and Human Services. Public Health Serv; 2008. Available on: Date of access 25.08.11

13. Chuchalin A.G., Sakharova G.M., Antonov N.S. et al. The complex treatment of tobacco dependence and prevention of chronic obstructive pulmonary disease caused by smoking. Profilaktika zabolevaniy i ukreplenie zdorov'ya 2003;2:44—50. Russian (Чучалин А.Г., Сахарова Г.М., Антонов Н.С. и др. Комплексное лечение табачной зависимости и профилактика хронической обструктивной болезни легких, вызванной курением. Профилактика заболеваний и укрепление здоровья 2003;2:44—50).

14. Rita F. Redberg, Emelia J. et al. Task Force on Performance Cardiovascular Disease in Adults: A Report of the American College of AHA/ACCF 2009 Performance Measures for Primary Prevention of Nurses Association. Circulation 2009;120:1296-1336;

15. Raw M., Slevin C. A survey of tobacco dependence treatment guidelines and systems in 45 Countries. December 2007. Available on: Date of access 25.08.11

16. New Zealand Guidelines Group. New Zealand Cardiovascular Guidelines Handbook: A summary resource for primary care practitioners. 2nd ed. Wellington: New Zealand Guidelines Group; 2009.

17. Pogosova G.V., Akhmedzhanov N.M., Koltunov I.E. Modern principles of pharmacological treatment of smoking and nicotine addiction. Profilakticheskaya meditsina 2009;5:29-34. Russian (Погосова Г.В., Ахмеджанов Н.М., Колтунов И.Е. Современные принципы медикаментозного лечения табакокурения и никотиновой зависимости. Профилактическая медицина 2009;5:29-34).

18. Andrew L. Pipe, MD,a Mark J. Eisenberg, MD,et al. Smoking Cessation and the Cardiovascular Specialist:Canadian Cardiovascular Society Position Paper. Canadian Journal of Cardiology 2011; 27:132–137.

19. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J 2007;28:2375-2414.

20. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010; 20: 2501-55.

21. Van de Werf F., Bax J., Betriu A. et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008;29(23):2909-45.

22. 2009 Focused Updates: ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention. Circulation 2008; 120: 2271 - 2306.

23. 2007 Chronic Angina Focused Update of the ACC/AHA 2002 Guidelines for the Management of Patients With Chronic Stable Angina. Circulation 2007; 116: 2762 - 2772.

24. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction. Circulation 2009; 120: 2271 - 2306.

25. Guidelines for the Management of Patients With Unstable Angina and Non– ST-Segment Elevation Myocardial Infarction: Executive Summary and Recommendations. Circulation 2009;102:1193-1209

26. Guidelines for the prevention of stroke in patients with stroke or transient is-chemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke 2011; 42: 227 - 276.

27. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42: 517 - 584.

28. Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update. J Am Coll Cardiol 2011; 57:1404-1423.

For citation:


Views: 400

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)